Cargando…
V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer worldwide and the third leading cause of cancer-related death. However, therapy options are limited leaving an urgent need to develop new strategies. Currently, targeting cancer cell lipid and cholesterol metabolism is gaining interest...
Autores principales: | Bartel, Karin, Winzi, Maria, Ulrich, Melanie, Koeberle, Andreas, Menche, Dirk, Werz, Oliver, Müller, Rolf, Guck, Jochen, Vollmar, Angelika M., von Schwarzenberg, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354746/ https://www.ncbi.nlm.nih.gov/pubmed/28036299 http://dx.doi.org/10.18632/oncotarget.14339 |
Ejemplares similares
-
A metabolic shift toward glycolysis enables cancer cells to maintain survival upon concomitant glutamine deprivation and V-ATPase inhibition
por: Lengauer, Florian, et al.
Publicado: (2023) -
Connecting lysosomes and mitochondria – a novel role for lipid metabolism in cancer cell death
por: Bartel, Karin, et al.
Publicado: (2019) -
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A
por: Zhang, Siwei, et al.
Publicado: (2015) -
Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?
por: Geisslinger, Franz, et al.
Publicado: (2020) -
Endolysosomal Cation Channels and Cancer—A Link with Great Potential
por: Grimm, Christian, et al.
Publicado: (2018)